Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.17 USD -8.59% Market Closed
Market Cap: 215.4m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Nektar Therapeutics
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nektar Therapeutics
Total Receivables Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
Total Receivables
$1.2m
CAGR 3-Years
-65%
CAGR 5-Years
-50%
CAGR 10-Years
-9%
Johnson & Johnson
NYSE:JNJ
Total Receivables
$16.2B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Total Receivables
$14.9B
CAGR 3-Years
8%
CAGR 5-Years
23%
CAGR 10-Years
17%
Pfizer Inc
NYSE:PFE
Total Receivables
$15.1B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
4%
Merck & Co Inc
NYSE:MRK
Total Receivables
$12.2B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Total Receivables
$12.1B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
13%

See Also

What is Nektar Therapeutics's Total Receivables?
Total Receivables
1.2m USD

Based on the financial report for Jun 30, 2024, Nektar Therapeutics's Total Receivables amounts to 1.2m USD.

What is Nektar Therapeutics's Total Receivables growth rate?
Total Receivables CAGR 10Y
-9%

Over the last year, the Total Receivables growth was -8%. The average annual Total Receivables growth rates for Nektar Therapeutics have been -65% over the past three years , -50% over the past five years , and -9% over the past ten years .

Back to Top